Predictive Oncology Inc (NASDAQ: POAI) is 137.80% higher on its value in year-to-date trading and has touched a low of $0.55 and a high of $3.76 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The POAI stock was last observed hovering at around $1.62 in the last trading session, with the day’s gains setting it 0.33%.
Currently trading at $1.95, the stock is 31.71% and 64.88% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.37 million and changing 20.37% at the moment leaves the stock 81.41% off its SMA200. POAI registered -37.10% loss for a year compared to 6-month gain of 107.93%.
The stock witnessed a 45.52% loss in the last 1 month and extending the period to 3 months gives it a 140.74%, and is 36.36% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.89% over the week and 13.90% over the month.
Predictive Oncology Inc (POAI) has around 34 employees, a market worth around $13.00M and $1.38M in sales. Profit margin for the company is -1013.00%. Distance from 52-week low is 254.55% and -48.14% from its 52-week high. The company has generated returns on investments over the last 12 months (-380.51%).
with sales reaching $350k over the same period.The EPS is expected to grow by 40.23% this year.
Predictive Oncology Inc (POAI) Top Institutional Holders
The shares outstanding are 6.67M, and float is at 6.56M with Short Float at 9.55%.
The top institutional shareholder in the company is ADVISORNET FINANCIAL, INC with over 95.0 shares valued at $99.0. The investor’s holdings represent 0.0023% of the POAI Shares outstanding.
Predictive Oncology Inc (POAI) Insider Activity
#####
